COVID-19 and Inflammatory Bowel Diseases: Risk Assessment, Shared Molecular Pathways, and Therapeutic Challenges

BACKGROUND: The novel coronavirus SARS-CoV-2 causing COVID-19 disease is yielding a global outbreak with severe threats to public health. In this paper, we aimed at reviewing the current knowledge about COVID-19 infectious risk status in inflammatory bowel disease (IBD) patients requiring immunosupp...

Descripción completa

Detalles Bibliográficos
Autores principales: Popa, Iolanda Valentina, Diculescu, Mircea, Mihai, Cătălina, Cijevschi-Prelipcean, Cristina, Burlacu, Alexandru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352130/
https://www.ncbi.nlm.nih.gov/pubmed/32714386
http://dx.doi.org/10.1155/2020/1918035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352130/
https://www.ncbi.nlm.nih.gov/pubmed/32714386
http://dx.doi.org/10.1155/2020/1918035

Ejemplares similares